Share Price | Rekvina Labs Ltd Stock Analysis & Recommendation

Q: Why is Rekvina Labs falling/rising?

As of 13-Jan, Rekvina Labs Ltd's stock price is rising, currently at Rs. 7.08, which reflects a significant increase of 2.58 or 57.33%. This rise is notable as it coincides with the stock hitting a new 52-week high today. The stock has outperformed the benchmark Sensex over the past week, gaining 57.33% while the Sensex has declined by 1.69%. Despite this positive short-term performance, there are underlying concerns. The stock has shown a decrease in investor participation, with delivery volume dropping by 94.45% compared to the 5-day average. Additionally, the stock has not reported results in the last six months, and its profits have decreased by 17% over the past year, indicating potential risks. Furthermore, while the stock has performed well over the last three years, it has underperformed the market over the past year, generating a return of 0.00%. Overall, the current rise in Rekvina Labs' stock price is driven by a recent surge in trading activity and the achievement of a new high, but it is tempered by significant risks and declining investor interest.

52-Week High: Rs.7.43 hit today

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

250 (-36.93%) Volume

Shareholding (Jun 2021)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

41.30%

Why is Rekvina Labs falling/rising?

13-Jan-2026

As of 13-Jan, Rekvina Labs Ltd's stock price is rising to Rs. 7.08, reflecting a 57.33% increase and hitting a new 52-week high. However, concerns arise from a 94.45% drop in delivery volume, a lack of recent financial results, and a 17% profit decrease over the past year, indicating potential risks despite the short-term gains.

View full answer

Which are the latest news on Rekvina Labs?

14-Jan-2026

No latest news for Rekvina Labs found.

Compare Rekvina Labs with Similar Stocks

Sun Pharma.Inds.Cresanto Global Divi's Lab.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Flat results in Sep 19

Risky - No result in last 6 months

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Drugs

Market cap

INR 4 Cr (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.02

Return on Equity

-28.40%

Price to Book

4.27

Revenue and Profits:

Net Sales:

(Quarterly Results - Sep 2019)

Net Profit:

Total Returns

Total Returns (Price + Dividend)

Company does not have enough history

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

Rekvina Labs Hits New 52-Week High of Rs.7.43 on 14 Jan 2026

Rekvina Labs Ltd reached a fresh 52-week high today, closing at Rs.7.43, reflecting a notable surge in momentum despite broader market softness. This milestone underscores the stock’s recent strength as it outperformed its sector and maintained a position above all key moving averages.

Read full news article

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

29-Jul-2019 18:12 | Source : BSE

Submission of Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018

Shareholding for the Period Ended June 30, 2019

20-Jul-2019 10:42 | Source : BSE

Rekvina Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here

Statement Of Investor Complaints For The Quarter Ended June 2019

18-Jul-2019 17:45 | Source : BSE

No.of Investor complaints pending at the beginning of the quarter	No.of Investor complaints received during the quarter	No.of Investor complaints disposed of during the quarter	No.of Investor complaints unresolved at the end of the quarter
0	0	0	0

Name of the Signatory	:-	Mukesh Shah
Designation	:-	Director

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

Rekvina Labs Ltd has announced 5:10 stock split, ex-date: 30 Apr 14

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-1.70%

EBIT Growth (5y)

-6.62%

EBIT to Interest (avg)

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.02

Sales to Capital Employed (avg)

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

-5.74%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

4.48

EV to EBIT

-4.46

EV to EBITDA

-4.46

EV to Capital Employed

4.46

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-25.30%

ROE (Latest)

-28.40%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bullish

RSI

Bearish

Bollinger Bands

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Dow Theory

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2021

Shareholding Compare (%holding)

Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Surbhit Mukesh Shah (15.22%)

Highest Public shareholder

Viralkumar Tribhovandas Patel (4.388%)

Individual Investors Holdings

51.98%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'19 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2019 is 0.00% vs 0.00% in Jun 2019",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2019 is 100.00% vs 95.24% in Jun 2019",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'19",
        "Jun'19",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.00",
          "val2": "-0.01",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.00",
          "val2": "-0.01",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Mar'19",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Mar 2019 is 0.00% vs -100.00% in Sep 2018",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Mar 2019 is -600.00% vs 40.00% in Sep 2018",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'19",
        "Sep'18",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.22",
          "val2": "-0.03",
          "chgp": "-633.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.21",
          "val2": "-0.03",
          "chgp": "-600.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'18",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2018 is -100.00% vs -50.00% in Dec 2017",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2018 is -50.00% vs 0.00% in Dec 2017",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'18",
        "Dec'17",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.01",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.03",
          "val2": "-0.02",
          "chgp": "-50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.03",
          "val2": "-0.02",
          "chgp": "-50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "-150.00%",
          "chgp": "150.00%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'19",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2019 is 0.00% vs -100.00% in Mar 2018",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2019 is -212.50% vs -300.00% in Mar 2018",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'19",
        "Mar'18",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.26",
          "val2": "-0.10",
          "chgp": "-160.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.25",
          "val2": "-0.08",
          "chgp": "-212.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Sep'19 - QoQ

Sep'19

Jun'19

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

0.00

-0.01

100.00%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

0.00

-0.01

100.00%

Operating Profit Margin (Excl OI)

0.00%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2019 is 0.00% vs 0.00% in Jun 2019

Standalone Net Profit

QoQ Growth in quarter ended Sep 2019 is 100.00% vs 95.24% in Jun 2019

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Mar'19

Mar'19

Sep'18

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-0.22

-0.03

-633.33%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

-0.21

-0.03

-600.00%

Operating Profit Margin (Excl OI)

0.00%

Values in Rs Cr.

Compare with Peers

Net Sales

Growth in half year ended Mar 2019 is 0.00% vs -100.00% in Sep 2018

Standalone Net Profit

Growth in half year ended Mar 2019 is -600.00% vs 40.00% in Sep 2018

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'18

Dec'18

Dec'17

Change(%)

Net Sales

0.00

0.01

-100.00%

Operating Profit (PBDIT) excl Other Income

-0.03

-0.02

-50.00%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

-0.03

-0.02

-50.00%

Operating Profit Margin (Excl OI)

0.00%

-150.00%

150.00%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in nine months ended Dec 2018 is -100.00% vs -50.00% in Dec 2017

Standalone Net Profit

YoY Growth in nine months ended Dec 2018 is -50.00% vs 0.00% in Dec 2017

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'19

Mar'19

Mar'18

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-0.26

-0.10

-160.00%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

-0.25

-0.08

-212.50%

Operating Profit Margin (Excl OI)

0.00%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2019 is 0.00% vs -100.00% in Mar 2018

Standalone Net Profit

YoY Growth in year ended Mar 2019 is -212.50% vs -300.00% in Mar 2018

All Annual Results

Company CV

About Rekvina Labs Ltd

Rekvina Labs Ltd

Micro Cap

Pharmaceuticals & Drugs

Rekvina Laboratories Ltd is committed to provide quality medication at affordable prices to the patients with a view to help bring down the healthcare costs.

Company Coordinates

Company Details

328 Paradise Complex, Sayajigunj Vadodara Gujarat : 390005

Tel: 91-265-2362966

http://www.rekvinalaboratories.com

rekvina@gmail.com

Registrar Details

Purva Shareregistry (India) Pvt Ltd , Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E], Mumbai

Rekvina Labs

1Day

52 Week

CASH

FII

DII

Promoter

Why is Rekvina Labs falling/rising?

Watch in Real-Time

Which are the latest news on Rekvina Labs?

Compare Rekvina Labs with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Flat results in Sep 19

Risky - No result in last 6 months

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

Returns Beta

News

Rekvina Labs Hits New 52-Week High of Rs.7.43 on 14 Jan 2026

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Shareholding for the Period Ended June 30, 2019

Statement Of Investor Complaints For The Quarter Ended June 2019

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Jun 2021

Shareholding Compare (%holding)

Quarterly Results Snapshot (Standalone) - Sep'19 - QoQ

Half Yearly Results Snapshot (Standalone) - Mar'19

Nine Monthly Results Snapshot (Standalone) - Dec'18

Annual Results Snapshot (Standalone) - Mar'19

About Rekvina Labs Ltd

Company Coordinates